Sandercock Colin has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 200000 shares of Cue Biopharma, Inc. ($CUE) on April 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 9, 2026 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 100,869,349 | 9999.99% | 0.20% |
| Sept. 26, 2025 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 56,328,348 | 9999.99% | 0.05% |
| Dec. 3, 2025 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 100,869,349 | 9999.99% | 0.07% |
| March 21, 2025 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 56,328,348 | 9999.99% | 0.36% |
| June 5, 2024 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 45,754,794 | 9999.99% | 0.13% |
| March 6, 2024 | Cue Biopharma, Inc. | $CUE | Sandercock Colin | SVP, GENERAL COUNSEL | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 45,754,794 | 9999.99% | 0.38% |